Shoulder Innovations Inc.
SI | NYSE
$17.61
+$0.09 (+0.51%)
At close: Sep 22, 2026, 4:00 PM ET
$17.96
+$0.35 (+1.99%)
After-hours:
Sep 22, 2026, 7:14 PM ET
+0.51%
(1D)Rating
Updated: Aug 15, 2026Key Statistics
Market Data
Market Cap $365.2M
1D Range
17.26 18.17
52W Range
10.92 24.60
Valuation (TTM)
PE -10.25
PB 2.92
EV/EBITDA -8.45
Valuation (NTM)
Forward PE N/A
Forward PEG 0.62
Price Target $23.50
Cash Flow
FCF Yield -17.1%
SBC Adj. FCF Yield -18.0%
SBC Impact -5.2%
Margins
Gross Margin 77.3%
Operating Margin -58.5%
FCF Margin -103.5%
Growth (CAGR)
Revenue 3Y | 5Y 95.7% |
N/A
Dil EPS 3Y | 5Y -37.6% |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA -23.1%
ROE -25.7%
ROIC -25.3%
Financial Health
Net Cash
$84.14M
Current Ratio 10.71
Interest Coverage 37.04
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered ...
Sector Healthcare
Industry Medical - Specialties
Employees 74
IPO Date Jul 30, 2025
Website www.shoulderinnovations.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$23.50
Upside
+33.45%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SI